0001140361-18-045056.txt : 20181212
0001140361-18-045056.hdr.sgml : 20181212
20181212214617
ACCESSION NUMBER: 0001140361-18-045056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181210
FILED AS OF DATE: 20181212
DATE AS OF CHANGE: 20181212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bjorklund Hakan
CENTRAL INDEX KEY: 0001583056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37906
FILM NUMBER: 181232091
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD, SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organogenesis Holdings Inc.
CENTRAL INDEX KEY: 0001661181
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-575-0775
MAIL ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: Avista Healthcare Public Acquisition Corp.
DATE OF NAME CHANGE: 20151215
4
1
form4.xml
FORM 4
X0306
4
2018-12-10
true
0001661181
Organogenesis Holdings Inc.
ORGO
0001583056
Bjorklund Hakan
C/O AVISTA HEALTHCARE PUBLIC ACQUISITION
CORP. 65 EAST 55TH STREET, 18TH FLOOR
NEW YORK
NY
10022
true
Class B Ordinary Shares
2018-12-10
4
D
0
243896
D
Class A Ordinary Shares
243896
69571
D
Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of Avista Healthcare Public Acquisition Corp. (the "Issuer"), the Class B ordinary shares, par value $0.0001 per share (the "Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date.
243,896 Class B ordinary shares were forfeited to the Issuer for no consideration prior to the closing of the Business Combination.
In connection with the closing of the Business Combination, the Issuer's name was changed to Organogenesis Holdings Inc.
/s/ Benjamin Silbert, Attorney-in-Fact
2018-12-12